abstract details

The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.

Long-term Glucocorticoid Use in Rheumatoid Arthritis


J Rheumatol. 2020 Oct 15;jrheum.201137. doi: 10.3899/jrheum.201137. Online ahead of print.

Maarten Boers 1, Theodore Pincus 1

Author Information

1 Epidemiology & Data Science, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Rush University, Chicago, Illinois, USA. Dr. Pincus is president of Medical History Services LLC, and holds a copyright and trademark on the Multidimensional Health Assessment Questionnaire (MDHAQ) and the Routine Assessment of Patient Index Data (RAPID3), for which he receives royalties and license fees, all of which are used to support further development of quantitative questionnaire measurement for patients and doctors in clinical rheumatology care. Address correspondence to Dr. T. Pincus, Rush University, 1611 West Harrison Street, Suite 510, Chicago, IL 60612, USA. Email: tedpincus@gmail.com.


We read with interest the article by Hanly and Lethbridge concerning long-term patterns of glucocorticoid (GC) use in older patients with rheumatoid arthritis (RA)1 Their report indicates that GC use has remained relatively stable over time, in contrast to greater use of disease-modifying antirheumatic drugs and biologic agents in the treat-to-target directive. They also report that rheumatologists prescribe lower doses than other physicians, and that the mean dose for rheumatologists has decreased over time.